Allergy Therapeutics (AGY)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

4.15p
   
  • Change Today:
      0.15p
  • 52 Week High: 6.00
  • 52 Week Low: 1.30
  • Currency: UK Pounds
  • Shares Issued: 4,766.44m
  • Volume: 469,773
  • Market Cap: £197.81m
  • RiskGrade: 268

Regulatory News

Update on funding 27-Aug-2024 07:00 RNS
Trading update for the year ended 30 June 2024 22-Jul-2024 07:01 RNS
Appointment of Nominated Adviser and Sole Broker 22-Jul-2024 07:00 RNS
Launch of new Company Long Term Incentive Plan 04-Jul-2024 14:22 RNS
Appointment of Non-Executive Director 27-Jun-2024 07:00 RNS
Progression of patient cohorts in PROTECT Trial 10-Jun-2024 07:00 RNS
Successful meetings with Paul Ehrlich Institut 03-Jun-2024 07:00 RNS
Further detail from G306 Phase III field trial 07-May-2024 07:00 RNS
Director Resignation 03-Apr-2024 07:00 RNS
Interim Results for six months ended 31 Dec 2023 27-Mar-2024 07:00 RNS
Update on funding 27-Mar-2024 07:00 RNS
VLP Peanut PROTECT Trial Update 12-Mar-2024 08:59 RNS
Appointment of Shaun Furlong to Board of Directors 11-Mar-2024 07:00 RNS
Result of AGM 08-Mar-2024 13:49 RNS
Half-Year Trading Update 2024 14-Feb-2024 07:00 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AGY Market Data

Currency UK Pounds
Share Price 4.15p
Change Today 0.15p
% Change 3.75 %
52 Week High 6.00
52 Week Low 1.30
Volume 469,773
Shares Issued 4,766.44m
Market Cap £197.81m
RiskGrade 268

AGY Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
18.12% below the market average18.12% below the market average18.12% below the market average18.12% below the market average18.12% below the market average
6.12% above the sector average6.12% above the sector average6.12% above the sector average6.12% above the sector average6.12% above the sector average
Price Trend
39.92% above the market average39.92% above the market average39.92% above the market average39.92% above the market average39.92% above the market average
38.78% above the sector average38.78% above the sector average38.78% above the sector average38.78% above the sector average38.78% above the sector average
Income Not Available
Growth
84.33% below the market average84.33% below the market average84.33% below the market average84.33% below the market average84.33% below the market average
87.88% below the sector average87.88% below the sector average87.88% below the sector average87.88% below the sector average87.88% below the sector average

AGY Dividends

No dividends found

Trades for 06-Sep-2024

Time Volume / Share Price
16:35 110,000 @ 4.15p
16:35 35,000 @ 4.15p
16:35 15,000 @ 4.15p
16:35 50,000 @ 4.15p
16:35 10,000 @ 4.15p

AGY Key Personnel

CEO Manuel Llobet

Top of Page